Show simple item record

dc.creatorMeghani, Salimah Hen
dc.date.accessioned2016-01-09T00:34:35Zen
dc.date.available2016-01-09T00:34:35Zen
dc.date.created2011-04en
dc.date.issued2011-04en
dc.identifierdoi:10.1111/j.1526-4637.2011.01074.xen
dc.identifier.bibliographicCitationPain medicine (Malden, Mass.) 2011 Apr; 12(4): 634-44en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Corporatization+of+pain+medicine:+implications+for+widening+pain+care+disparities.&title=Pain+medicine+&volume=12&issue=4&date=2011-04&au=Meghani,+Salimah+Hen
dc.identifier.urihttp://dx.doi.org/10.1111/j.1526-4637.2011.01074.xen
dc.identifier.urihttp://hdl.handle.net/10822/1017726en
dc.description.abstractThe current health care system in the United States is structured in a way that ensures that more opportunity and resources flow to the wealthy and socially advantaged. The values intrinsic to the current profit-oriented culture are directly antithetical to the idea of equitable access. A large body of literature points to disparities in pain treatment and pain outcomes among vulnerable groups. These disparities range from the presence of disproportionately higher numbers and magnitude of risk factors for developing disabling pain, lack of access to primary care providers, analgesics and interventions, lack of referral to pain specialists, longer wait times to receive care, receipt of poor quality of pain care, and lack of geographical access to pharmacies that carry opioids. This article examines the manner in which the profit-oriented culture in medicine has directly and indirectly structured access to pain care, thereby widening pain treatment disparities among vulnerable groups. Specifically, the author argues that the corporatization of pain medicine amplifies disparities in pain outcomes in two ways: 1) directly through driving up the cost of pain care, rendering it inaccessible to the financially vulnerable; and 2) indirectly through an interface with corporate loss-aversion/risk management culture that draws upon irrelevant social characteristics, thus worsening disparities for certain populations. Thus, while financial vulnerability is the core reason for lack of access, it does not fully explain the implications of corporate microculture regarding access. The effect of corporatization on pain medicine must be conceptualized in terms of overt access to facilities, providers, pharmaceuticals, specialty services, and interventions, but also in terms of the indirect or covert effect of corporate culture in shaping clinical interactions and outcomes.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:338515en
dc.subjectCultureen
dc.subjectHealthen
dc.subjectLiteratureen
dc.subjectMedicineen
dc.subjectPainen
dc.subjectRisken
dc.subjectRisk Managementen
dc.subjectValuesen
dc.subject.classificationValue / Quality of Lifeen
dc.subject.classificationHealth Careen
dc.subject.classificationRight to Health Careen
dc.subject.classificationAllocation of Health Care Resourcesen
dc.subject.classificationBusiness Ethicsen
dc.titleCorporatization of Pain Medicine: Implications for Widening Pain Care Disparitiesen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885